课题基金 / 基金详情

Immunobiology of Influenza Virus Infection: Approaches for an Emerging Zoonotic D

Immunobiology of Influenza Virus Infection: Approaches for an Emerging Zoonotic D
流感病毒感染的免疫生物学:新出现的人畜共患病 D 的方法
批准号:
7334084
负责人:
RALPH A TRIPP
金额:
$2.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-06-15 至 2008-05-31

项目摘要

项目成果

RALPH A TRIPP的其他基金

相似基金

相关文献

中文摘要
翻译
大多数新出现的传染病都是人畜共患病,即 在人和动物之间传播,导致两个物种感染。许多 这些媒介中最危险和最容易传播的是病毒。大多数 新出现或重新出现的人类病毒缺乏有效的疫苗或抗病毒药物 治疗最近出现的高致病性禽流感病毒H5N1 强调了这种未满足的需求。基础研究和应用研究的最新进展 提供了一个前所未有的机会来了解病毒之间的相互作用, 宿主和免疫系统,特别是免疫细胞和分子的问题 参与免疫的产生、效应器机制以及参与免疫的机制 免疫记忆反应的产生和维持。本次会议将 聚集来自学术界、政府和其他机构的基础和应用病毒免疫学家, 工业促进有效地将基础研究的新发现转化为有效的 疫苗和治疗。会议的目标是加速抗病毒疫苗和 治疗发展,以促进对新出现的病毒威胁的快速反应, 会议的焦点是流感病毒。
英文摘要
The majority of emerging infectious diseases are of zoonotic origin, i.e. transmissible between humans and animals causing infection in both species. Many of the most dangerous and easily transmitted of these agents are viruses. The majority of the emerging or re-emerging human viruses lack an effective vaccine or anti-viral drug treatment. The recent emergence of the highly pathogenic avian influenza virus H5N1 emphasizes this unmet need. Recent advances in basic and applied research have provided an unparalleled opportunity to understand the interplay between the virus, the host, and the immune system, particularly on matters of immune cells and molecules involved in the generation of immunity, effector mechanisms, and mechanisms involved in the generation and maintenance of immune memory responses. This meeting will assemble basic and applied viral immunologists from academia, government, and industry to foster effective translation of new findings in basic research into effective vaccines and therapies. The goal of the meeting is to accelerate anti-viral vaccine and therapeutic development, to facilitate a rapid response to the threat of emerging viruses, with the focus of the meeting centered on influenza viruses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RSV Nanocapsule Vaccine Engineered with a G Protein Peptide Payload
  • 批准号:
    8636392
  • 项目类别:
  • 资助金额:
    $56.38万
  • 财政年份:
    2010
  • 负责人:
    RALPH A TRIPP
  • 依托单位:
RSV Nanocapsule Vaccine Engineered with a G Protein Peptide Payload
  • 批准号:
    8450155
  • 项目类别:
  • 资助金额:
    $52.82万
  • 财政年份:
    2010
  • 负责人:
    RALPH A TRIPP
  • 依托单位:
RSV Nanocapsule Vaccine Engineered with a G Protein Peptide Payload
  • 批准号:
    7902985
  • 项目类别:
  • 资助金额:
    $59.31万
  • 财政年份:
    2010
  • 负责人:
    RALPH A TRIPP
  • 依托单位:
RSV Nanocapsule Vaccine Engineered with a G Protein Peptide Payload
  • 批准号:
    8051743
  • 项目类别:
  • 资助金额:
    $57.32万
  • 财政年份:
    2010
  • 负责人:
    RALPH A TRIPP
  • 依托单位:
海外基金